Analyst Information for Vertex Pharmaceuticals Incorporated

$ 221.495   2.125 (+0.97%) Volume: 566.17k 1:16 PM EST Dec 10, 2019
Consensus Rating Average
Consensus Rating for VRTX is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.47
Previous Average Recommendation 1.62
Change in Average Recommendation -0.15
Number of Analysts Reporting 18
Strong Buy
1.0
Current: 1.47
Previous: 1.62
Change: -0.15
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 387
Rank Recommendation relative to companies in its industry 263
Ranked 263 in Industry
1387 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 13
Analysts recommending Moderate Buy 1
Analysts recommending Hold 4
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 13 11 9 9
Moderate Buy 1 1 1 2
Hold 4 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.62 1.70 1.72

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.